ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry P20333


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name TNR1B_HUMAN
Primary accession number P20333
Secondary accession numbers B1AJZ3 Q16042 Q6YI29 Q9UIH1
Integrated into Swiss-Prot on February 1, 1991
Sequence was last modified on May 27, 2002 (Sequence version 3)
Annotations were last modified on    June 16, 2009 (Entry version 121)
Name and origin of the protein
Protein name Tumor necrosis factor receptor superfamily member 1B [Precursor]
Synonyms Tumor necrosis factor receptor 2
TNF-R2
Tumor necrosis factor receptor type II
p75
p80 TNF-alpha receptor
CD120b antigen
Etanercept
Contains Tumor necrosis factor receptor superfamily member 1b, membrane form
Tumor necrosis factor-binding protein 2
     (TBPII)
     (TBP-2)
Gene name
Name: TNFRSF1B
Synonyms: TNFBR, TNFR2
From
Homo sapiens (Human) [TaxID: 9606] 
Taxonomy Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo.
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ARG-196.
DOI=10.1073/pnas.87.21.8331; PubMed=2172983 [NCBI, ExPASy, EBI, Israel, Japan]
Kohno T., Brewer M.T., Baker S.L., Schwartz P.E., King M.W., Hale K.K., Squires C.H., Thompson R.C., Vannice J.L.;
"A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor.";
Proc. Natl. Acad. Sci. U.S.A. 87:8331-8335(1990).
[2]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
DOI=10.1126/science.2160731; PubMed=2160731 [NCBI, ExPASy, EBI, Israel, Japan]
Smith C.A., Davis T., Anderson D., Solam L., Beckmann M.P., Jerzy R., Dower S.K., Cosman D., Goodwin R.G.;
"A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins.";
Science 248:1019-1023(1990).
[3]
NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
DOI=10.1006/geno.1996.0327; PubMed=8661109 [NCBI, ExPASy, EBI, Israel, Japan]
Beltinger C.P., White P.S., Maris J.M., Sulman E.P., Jensen S.J., Lepaslier D., Stallard B.J., Goeddel D.V., Desauvage F.J., Brodeur G.M.;
"Physical mapping and genomic structure of the human TNFR2 gene.";
Genomics 35:94-100(1996).
[4]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), SUBCELLULAR LOCATION, AND FUNCTION OF ISOFORM 2.
DOI=10.1093/intimm/dxh014; PubMed=14688072 [NCBI, ExPASy, EBI, Israel, Japan]
Lainez B., Fernandez-Real J.M., Romero X., Esplugues E., Canete J.D., Ricart W., Engel P.;
"Identification and characterization of a novel spliced variant that encodes human soluble tumor necrosis factor receptor 2.";
Int. Immunol. 16:169-177(2004).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A.;
"Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
[6]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS MET-187; ARG-196; LYS-232; THR-236; PRO-264 AND ARG-295.
NIEHS SNPs program;
Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases.
[7]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ARG-196; LYS-232; PRO-269 AND ARG-301.
SeattleSNPs variation discovery resource;
Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
[8]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
DOI=10.1038/nature04727; PubMed=16710414 [NCBI, ExPASy, EBI, Israel, Japan]
Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H., Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L., Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J., Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J., Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N., Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
"The DNA sequence and biological annotation of human chromosome 1.";
Nature 441:315-321(2006).
[9]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W., Venter J.C.;
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
[10]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
TISSUE=PNS;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[11]
PROTEIN SEQUENCE OF 23-40; 65-69; 136-141; 300-306 AND 346-362.
PubMed=2173696 [NCBI, ExPASy, EBI, Israel, Japan]
Loetscher H., Schlaeger E.J., Lahm H.-W., Pan Y.-C.E., Lesslauer W., Brockhaus M.;
"Purification and partial amino acid sequence analysis of two distinct tumor necrosis factor receptors from HL60 cells.";
J. Biol. Chem. 265:20131-20138(1990).
[12]
PROTEIN SEQUENCE OF 27-37.
TISSUE=Urine;
PubMed=8015639 [NCBI, ExPASy, EBI, Israel, Japan]
Suzuki J., Tomizawa S., Arai H., Seki Y., Maruyama K., Kuroume T.;
"Purification of two types of TNF inhibitors in the urine of the patient with chronic glomerulonephritis.";
Nephron 66:386-390(1994).
[13]
PROTEIN SEQUENCE OF 27-31.
TISSUE=Urine;
PubMed=2153136 [NCBI, ExPASy, EBI, Israel, Japan]
Engelmann H., Novick D., Wallach D.;
"Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors.";
J. Biol. Chem. 265:1531-1536(1990).
[14]
NUCLEOTIDE SEQUENCE [MRNA] OF 37-461 (ISOFORM 1).
DOI=10.1016/1043-4666(90)90022-L; PubMed=1966549 [NCBI, ExPASy, EBI, Israel, Japan]
Dembic Z., Loetscher H., Gubler U., Pan Y.C., Lahm H.-W., Gentz R., Brockhaus M., Lesslauer W.;
"Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences.";
Cytokine 2:231-237(1990).
[15]
NUCLEOTIDE SEQUENCE [MRNA] OF 116-461 (ISOFORM 1), PARTIAL PROTEIN SEQUENCE, AND VARIANT ARG-196.
DOI=10.1073/pnas.87.16.6151; PubMed=2166946 [NCBI, ExPASy, EBI, Israel, Japan]
Heller R.A., Song K., Onasch M.A., Fischer W.H., Chang D., Ringold G.M.;
"Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor.";
Proc. Natl. Acad. Sci. U.S.A. 87:6151-6155(1990).
[16]
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 154-183, AND VARIANTS ARG-196 AND LYS-232.
DOI=10.1038/sj.gene.6363700; PubMed=11197692 [NCBI, ExPASy, EBI, Israel, Japan]
Tsuchiya N., Komata T., Matsushita M., Ohashi J., Tokunaga K.;
"New single nucleotide polymorphisms in the coding region of human TNFR2: association with systemic lupus erythematosus.";
Genes Immun. 1:501-503(2000).
[17]
CHARACTERIZATION.
PubMed=1328224 [NCBI, ExPASy, EBI, Israel, Japan]
Pennica D., Lam V.T., Mize N.K., Weber R.F., Lewis M., Fendly B.M., Lipari M.T., Goeddel D.V.;
"Biochemical properties of the 75-kDa tumor necrosis factor receptor. Characterization of ligand binding, internalization, and receptor phosphorylation.";
J. Biol. Chem. 267:21172-21178(1992).
[18]
INTERACTION WITH TRAF2.
DOI=10.1016/0092-8674(94)90532-0; PubMed=8069916 [NCBI, ExPASy, EBI, Israel, Japan]
Rothe M., Wong S.C., Henzel W.J., Goeddel D.V.;
"A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor.";
Cell 78:681-692(1994).
[19]
X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 419-428 IN COMPLEX WITH TRAF2.
DOI=10.1038/19110; PubMed=10206649 [NCBI, ExPASy, EBI, Israel, Japan]
Park Y.C., Burkitt V., Villa A.R., Tong L., Wu H.;
"Structural basis for self-association and receptor recognition of human TRAF2.";
Nature 398:533-538(1999).
[20]
VARIANTS ARG-196 AND LYS-232.
DOI=10.1002/1529-0131(200112)44:12<2819::AID-ART469>3.0.CO;2-2; PubMed=11762942 [NCBI, ExPASy, EBI, Israel, Japan]
Morita C., Horiuchi T., Tsukamoto H., Hatta N., Kikuchi Y., Arinobu Y., Otsuka T., Sawabe T., Harashima S., Nagasawa K., Niho Y.;
"Association of tumor necrosis factor receptor type II polymorphism 196R with systemic lupus erythematosus in the Japanese: molecular and functional analysis.";
Arthritis Rheum. 44:2819-2827(2001).
[21]
VARIANT ARG-196.
DOI=10.1210/jc.87.8.3977; PubMed=12161545 [NCBI, ExPASy, EBI, Israel, Japan]
Peral B., San Millan J.L., Castello R., Moghetti P., Escobar-Morreale H.F.;
"Comment: the methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism.";
J. Clin. Endocrinol. Metab. 87:3977-3983(2002).
Comments
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
M55994; AAA36755.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M32315; AAA59929.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U52165; AAC50622.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U52156; AAC50622.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U52157; AAC50622.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U52158; AAC50622.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U52159; AAC50622.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U52160; AAC50622.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U52161; AAC50622.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U52162; AAC50622.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U52163; AAC50622.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U52164; AAC50622.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AY148473; AAN72434.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BT019927; AAV38730.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AY264804; AAO89076.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AY342040; AAP88939.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AL031276; CAI19225.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AL357835; CAI19225.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AL357835; CAH73721.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AL031276; CAH73721.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
CH471130; EAW71733.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC052977; AAH52977.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
S63368; AAB19824.2; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M35857; AAA63262.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AB030950; BAA89053.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
IPI IPI00023501; -.
IPI00473089; -.
PIR A35356; A35356.
RefSeq NP_001057.1; -.
UniGene Hs.256278
3D structure databases
PDB
1CA9; X-ray; 2.30 A; G/H=420-428.[ExPASy / RCSB / EBI]
PDBsum 1CA9; -.
ModBase P20333.
Protein-protein interaction databases
DIP DIP:78N; -.
IntAct P20333; 97.
PTM databases
PhosphoSite P20333; -.
Enzyme and pathway databases
Pathway_Interaction_DB tnfpathway; TNF receptor signaling pathway.
Organism-specific databases
GeneCards GC01P012161; -.
H-InvDB HIX0023621; -.
HGNC HGNC:11917; TNFRSF1B.
GenAtlas TNFRSF1B.
HPA CAB013045; -.
HPA004796; -.
MIM 191191; gene. [NCBI / EBI]
PharmGKB PA36610; -.
Gene expression databases
ArrayExpress P20333; -.
Bgee P20333; -.
CleanEx HS_TNFRSF1B; -.
GermOnline ENSG00000028137; Homo sapiens.
Ontologies
GO
GO:0005737; Cellular component: cytoplasm (inferred from direct assay from HPA).
GO:0005576; Cellular component: extracellular region (inferred from electronic annotation from UniProtKB-SubCell).
GO:0016021; Cellular component: integral to membrane (inferred from electronic annotation from UniProtKB-KW).
GO:0045121; Cellular component: membrane raft (inferred from direct assay from UniProtKB).
GO:0005634; Cellular component: nucleus (inferred from direct assay from HPA).
GO:0005886; Cellular component: plasma membrane (inferred from electronic annotation from UniProtKB-SubCell).
GO:0005031; Molecular function: tumor necrosis factor receptor activity (traceable author statement from ProtInc).
GO:0006915; Biological process: apoptosis (inferred from electronic annotation from UniProtKB-KW).
QuickGo view.
Family and domain databases
InterPro IPR001368; TNFR_Cys_rich_reg.
Graphical view of domain structure.
Pfam PF00020; TNFR_c6; 2.
Pfam graphical view of domain structure.
SMART SM00208; TNFR; 4.
SMART graphical view of domain structure.
PROSITE PS00652; TNFR_NGFR_1; 2.
PS50050; TNFR_NGFR_2; 3.
PROSITE graphical view of domain structure (profiles).
Proteomic databases
PeptideAtlas P20333; -.
PRIDE P20333; -.
Genome annotation databases
Ensembl ENSG00000028137; Homo sapiens. [Contig view]
GeneID 7133; -.
KEGG hsa:7133; -.
Phylogenomic databases
HOGENOM P20333; -.
HOVERGEN P20333; -.
OMA P20333; KDEQVPF.
Other
DrugBank DB00005; Etanercept.
DB00065; Infliximab.
NextBio 27909; -.
PMAP-CutDB P20333; -.
SOURCE TNFRSF1B; Homo sapiens.
ProtoNet P20333.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
3D-structure; Alternative splicing; Apoptosis; Cell membrane; Direct protein sequencing; Disulfide bond; Glycoprotein; Membrane; Pharmaceutical; Phosphoprotein; Polymorphism; Receptor; Repeat; Secreted; Signal; Transmembrane.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom   To Length Description FTId
SIGNAL   1    22  22      
CHAIN   23   461  439     Tumor necrosis factor receptor superfamily member 1b, membrane form. PRO_0000034548
CHAIN   27     ?        Tumor necrosis factor-binding protein 2. PRO_0000034549
TOPO_DOM   23   257  235     Extracellular (Potential). 
TRANSMEM   258   287  30     Potential. 
TOPO_DOM   288   461  174     Cytoplasmic (Potential). 
REPEAT   39    76  38     TNFR-Cys 1. 
REPEAT   77   118  42     TNFR-Cys 2. 
REPEAT   119   162  44     TNFR-Cys 3. 
REPEAT   163   201  39     TNFR-Cys 4. 
CARBOHYD   171   171        N-linked (GlcNAc...) (Potential). 
CARBOHYD   193   193        N-linked (GlcNAc...) (Potential). 
DISULFID   40    53        By similarity. 
DISULFID   54    67        By similarity. 
DISULFID   57    75        By similarity. 
DISULFID   78    93        By similarity. 
DISULFID   96   110        By similarity. 
DISULFID   100   118        By similarity. 
DISULFID   120   126        By similarity. 
DISULFID   134   143        By similarity. 
DISULFID   137   161        By similarity. 
DISULFID   164   179        By similarity. 
VAR_SEQ   263   268        GLIVGV -> ASLACR (in isoform 2). VSP_011826
VAR_SEQ   269   461        Missing (in isoform 2). VSP_011827
VARIANT   187   187  1     V -> M (in dbSNP:rs2228494 [NCBI]). VAR_017176 
VARIANT   196   196  1     M -> R (frequent polymorphism; seems to be associated with hyperandrogenism, polycystic ovary syndrome (PCOS) and systemic lupus erythematosus; dbSNP:rs1061622 [NCBI]). VAR_015434 
VARIANT   232   232  1     E -> K (in dbSNP:rs5746026 [NCBI]). VAR_015435 
VARIANT   236   236  1     A -> T (in dbSNP:rs5746027 [NCBI]). VAR_017177 
VARIANT   264   264  1     L -> P (in dbSNP:rs2229700 [NCBI]). VAR_017178 
VARIANT   269   269  1     T -> P (in dbSNP:rs17879042 [NCBI]). VAR_017179 
VARIANT   295   295  1     Q -> R (in dbSNP:rs5746032 [NCBI]). VAR_017180 
VARIANT   301   301  1     P -> R (in dbSNP:rs17883432 [NCBI]). VAR_017181 
CONFLICT   35    37        EPG -> APT (in Ref. 12; AA sequence). 
CONFLICT   98    98        S -> P (in Ref. 4; AAN72434). 
CONFLICT   102   102        S -> P (in Ref. 4; AAN72434). 
CONFLICT   141   141        R -> P (in Ref. 15; AAA63262). 
CONFLICT   363   363        A -> T (in Ref. 15; AAA63262). 
Sequence information
Length: 461 AA [This is the length of the unprocessed precursor] Molecular weight: 48291 Da [This is the MW of the unprocessed precursor] CRC64: 603D0AE1CD69ACBF [This is a checksum on the sequence]
        10         20         30         40         50         60 
MAPVAVWAAL AVGLELWAAA HALPAQVAFT PYAPEPGSTC RLREYYDQTA QMCCSKCSPG 

        70         80         90        100        110        120 
QHAKVFCTKT SDTVCDSCED STYTQLWNWV PECLSCGSRC SSDQVETQAC TREQNRICTC 

       130        140        150        160        170        180 
RPGWYCALSK QEGCRLCAPL RKCRPGFGVA RPGTETSDVV CKPCAPGTFS NTTSSTDICR 

       190        200        210        220        230        240 
PHQICNVVAI PGNASMDAVC TSTSPTRSMA PGAVHLPQPV STRSQHTQPT PEPSTAPSTS 

       250        260        270        280        290        300 
FLLPMGPSPP AEGSTGDFAL PVGLIVGVTA LGLLIIGVVN CVIMTQVKKK PLCLQREAKV 

       310        320        330        340        350        360 
PHLPADKARG TQGPEQQHLL ITAPSSSSSS LESSASALDR RAPTRNQPQA PGVEASGAGE 

       370        380        390        400        410        420 
ARASTGSSDS SPGGHGTQVN VTCIVNVCSS SDHSSQCSSQ ASSTMGDTDS SPSESPKDEQ 

       430        440        450        460 
VPFSKEECAF RSQLETPETL LGSTEEKPLP LGVPDAGMKP S 

P20333 in FASTA format

View entry in raw text format (no links)
Report form for errors/updates in this UniProtKB/Swiss-Prot entry

BLAST logo BLAST submission on ExPASy/SIB
or at NCBI (USA)
Tools Sequence analysis tools: ProtParam, ProtScale, Compute pI/Mw, PeptideMass, PeptideCutter, Dotlet (Java)
PROSITE logo ScanProsite, MotifScan SWISS-MODEL Submit a homology modeling request to SWISS-MODEL
NPSA logo NPSA Sequence analysis tools

ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
 Hosted by ch flag SIB Switzerland Mirror sites: Australia  Brazil  Canada  China  Korea
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!